Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ITGB3 | P05106 | 11/20 | 0.51 |
| ▸ | ITGA2B | P08514 | 11/20 | 0.51 |
| ▸ | F2R | P25116 | 8/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7439547 | 0.91 | ITGB3 (0.48) | ITGB3ITGA2BF2RHTTALDH1A1 | |
| Hydrochloric Acid SCHEMBL7439542 | 0.90 | ITGB3 (0.47) | ITGB3ITGA2BF2RHTTALDH1A1 | |
| SCHEMBL7440559 | 0.86 | ITGB3 (0.64) | ITGB3ITGA2BF2R | |
| SCHEMBL7441748 | 0.84 | CHRM1 (0.44) | ITGB3ITGA2BF2RHTTALDH1A1 | |
| Trifluoroacetic Acid SCHEMBL7501292 | 0.84 | ITGB3 (0.45) | ITGB3ITGA2BF2R | |
| SCHEMBL7444452 | 0.83 | ITGB3 (0.47) | ITGB3ITGA2BF2RCHRM1 | |
| Hydrochloric Acid SCHEMBL7444449 | 0.83 | ITGB3 (0.46) | ITGB3ITGA2BF2RCHRM1 | |
| SCHEMBL7451967 | 0.81 | ITGB3 (0.46) | ITGB3ITGA2BF2RHTTALDH1A1 | |
| SCHEMBL7451961 | 0.81 | ITGB3 (0.51) | ITGB3ITGA2BF2RHTTALDH1A1 | |
| SCHEMBL7503334 | 0.80 | ITGB3 (0.74) | ITGB3ITGA2BF2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6384028-B1 | TREATMENT OF CARDIOVASCULAR DISORDERS, ANTICOAGULANTS AND VALVE REPLACEMENT | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| EP-0869944-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |
| WO-1996029309-A1 | N-ACYLPIPERIDINYLCARBONYLAMINOCARBOXYLIC ACIDS AND THEIR USE AS GLYCOPROTEIN IIB/IIa ANTAGONISTS AND FIBRINOGEN-BLOOD PLATELETS BINDING INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1996-09-26 | — | — | WO | disclosed |